A settlement has been reached between Texas and AstraZeneca, resulting in the pharmaceutical company paying the state nearly $34 million. This payment is to settle allegations of an illegal kickback scheme used to influence Medicaid prescriptions.

The scheme allegedly involved improper influence over prescription decisions for Medicaid patients. Texas is recovering the funds as a result of the settlement.

Further details about the settlement and allegations against AstraZeneca can be found through FOX 4 News Dallas-Fort Worth, the source of this information.